MedPath

Patterns and processes of cognitive and behavioural changes in patients with COPD receiving smoking reduction treatment - The REDUQ II study

Conditions
Chronic Obstructive Pulmonary Disease (COPD), Smoking, Smoking cessation, Smoking reduction, Tobacco addiction, COPD, Lung emphysema, Chronic bronchitis, Nicotine dependence, Smoking reduction, single case experimental design (SCED).
Registration Number
NL-OMON22274
Lead Sponsor
Medisch Spectrum Twente hospital and University of Twente
Brief Summary

/A

Detailed Description

Not available

Recruitment & Eligibility

Status
Pending
Sex
Not specified
Target Recruitment
32
Inclusion Criteria

1. Clinical COPD, GOLD stage I-IV;

2. Age 40-80 years;

Exclusion Criteria

1. Motivated to quit smoking within 1 month from baseline (= ready to quit);

2. Not able to speak, read and write Dutch;

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
- (biochemically validated) smoking status<br /><br>- motivation/intention to quit<br /><br>- self-efficacy<br /><br>- attitudes towards smoking cessation<br />
Secondary Outcome Measures
NameTimeMethod
- social influence<br /><br>- desire or urge to smoke <br /><br>- treatment adherence (scheduled reduced smoking)<br /><br>- use of NRT and/or anti-smoking medication<br />
© Copyright 2025. All Rights Reserved by MedPath